Filtration improves the performance of a high-throughput screen for anti-mycobacterial compounds

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Cheng, Nancy ^a   Porter, Melissa A ^a   Frick, Lloyd W ^d   Nguyen, Yvonne ^a   Hayden, Jennifer D ^b   Young, Ellen F ^b   Braunstein, Miriam S ^b   Hull Ryde, Emily A ^a   Janzen, William P ^a,c  

^a UNC Hamner Institute for Drug Safety Sciences   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NORTH CAROLINA   (United States)

^d DMPK Advisors   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMYCOBACTERIAL AGENT; TUBERCULOSTATIC AGENT;

ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; COLONY FORMATION; COLONY FORMING UNIT; CONTROLLED STUDY; CULTURE MEDIUM; FILTRATION; HIGH THROUGHPUT SCREENING; HYDROPHOBICITY; MICROSCOPY; MYCOBACTERIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PROPENSITY SCORE; TUBERCULOSIS; DEVICES; DRUG EFFECTS; DRUG SCREENING; MICROPORE FILTER; PHYSIOLOGY; PROCEDURES; REPRODUCIBILITY;

ANTITUBERCULAR AGENTS; DRUG EVALUATION, PRECLINICAL; FILTRATION; HIGH-THROUGHPUT SCREENING ASSAYS; MICROPORE FILTERS; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; REPRODUCIBILITY OF RESULTS;

EID: 84900394823     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096348     Document Type: Article

References (30)

1. World Health Organization (2012) Global Tuberculosis Report - 2012; World Health Organization: Geneva. Available: http://who.int/tb/publications/global- report/en/. Accessed 2014 January 10.
2. Kumar A (2012) TB India 2012 Report. Dept of Health and Family Affairs (ed.). Ministry of Health, Nirman Bhawan, New Delhi - 110 108.
3. Osborne R (2013) First novel anti-tuberculosis drug in 40 years. Nature Biotechnology 31:89-91.
4. Snider GL (1997) Tuberculosis then and now: a personal perspective on the last 50 years. Annals of Internal Medicine 126:237-243.
5. Cooper CB (2013) Development of Mycobacterium tuberculosis whole cell screening hits as potential antituberculosis agents. Journal of Medicinal Chemistry 56:7755-7760.
6. Abubakar I, Zignol M, Falzon D, Raviglione M, Ditiu L, et al. (2013) Drug-resistant tuberculosis: time for visionary political leadership. Lancet Infect Dis 13:529-539.
7. Gruppo V, Johnson CM, Marietta KS, Scherman H, Zink EE, et al. (2006) Rapid microbiologic and pharmacologic evaluation of experimental compounds against Mycobacterium tuberculosis. Antimicrob Agents Chemother 50:1245-1250.
8. Ananthan S, Faaleolea ER, Goldman RC, Hobrath JV, Kwong CD, et al. (2009) High-throughput screening for inhibitors of Mycobacterium tuberculosis H37Rv. Tuberculosis 89:334-353.
9. Andries K, Verhasselt P, Guillemont J, Gohlmann HW, Neefs JM, et al. (2005) A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science 307:223-227. (Pubitemid 40116230)
10. Betterncourt P, Pires D, Carmo N, Anes E (2010) Application of Confocal Microscopy for Quantification of Intracellular Mycobacteria in Macrophages. Microscopy: Science, Technology, Applications and Education:614.
11. Stover CK, Warrener P, VanDevanter DR, Sherman DR, Arain TM, et al. (2000) A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis. Nature 405:962-966. (Pubitemid 30435054)
12. Matsumoto M, Hashizume H, Tomishige T, Kawasaki M, Tsubouchi H, et al. (2006) OPC-67683, a nitro-dihydro-imidazooxazole derivative with promising action against tuberculosis in vitro and in mice. PLoS Medicine 3:e466.
13. Protopopova M, Hanrahan C, Nikonenko B, Samala R, Chen P, et al. (2005) Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. The Journal of Antimicrobial Chemotherapy 56:968-974. (Pubitemid 41631930)
14. 2155: is there a clue for the unique transformability of the strain? Microbiology 151:2075-2086.
15. Davis BD, Dulbecco R, Eisen HN, Ginsberg HS (1979) Microbiology, Harper & Row, Publishers, New York.
16. Meyers PR, Bourn WR, Steyn LM, van Helden PD, Beyers AD, et al. (1998) Novel method for rapid measurement of growth of mycobacteria in detergent-free media. Journal of Clinical Microbiology 36:2752-2754. (Pubitemid 28380993)
17. Tobias HJ, Schafer MP, Pitesky M, Fergenson DP, Horn J, et al. (2005) Bioaerosol mass spectrometry for rapid detection of individual airborne Mycobacterium tuberculosis H37Ra particles. Applied and Environmental Microbiology 71:6086-6095. (Pubitemid 41456905)
18. Taneja NK, Tyagi JS (2007) Resazurin reduction assays for screening of antitubercular compounds against dormant and actively growing Mycobacterium tuberculosis, Mycobacterium bovis BCG and Mycobacterium smegmatis. The Journal of Antimicrobial Chemotherapy 60:288-293. (Pubitemid 47243876)
19. Lambrecht RS, Carriere JF, Collins MT (1988) A model for analyzing growth kinetics of a slowly growing Mycobacterium spp. Applied and Environmental Microbiology 54:910-916.
20. Shin SJ, Han JH, Manning EJ, Collins MT (2007) Rapid and reliable method for quantification of Mycobacterium paratuberculosis by use of the BACTEC MGIT 960 system. Journal of Clinical Microbiology 45:1941-1948. (Pubitemid 46933930)
21. Pathak S, Awuh JA, Leversen NA, Flo TH, Asjo B (2012) Counting mycobacteria in infected human cells and mouse tissue: a comparison between qPCR and CFU. PloS ONE 7:e34931.
22. Koch AL (1968) Theory of the angular dependence of light scattered by bacteria and similar-sized biological objects. J Theor Biol 18:133-156.
23. Koch AL (1970) Turbidity measurements of bacterial cultures in some available commercial instruments. Anal Biochem 38:252-259.
24. Lawrence JV, Maier S (1977) Correction for the inherent error in optical density readings. Applied and Environmental Microbiology 33:482-484. (Pubitemid 8099803)
25. van de Hulst HC (1981) Light scattering by small particles. Dover Publications, New York.
26. Larson EM, Doughman DJ, Gregerson DS, Obritsch WF (1997) A new, simple, nonradioactive, nontoxic in vitro assay to monitor corneal endothelial cell viability. Invest Ophthalmol Vis Sci 38:1929-1933. (Pubitemid 27407511)
27. O'Brien J, Wilson I, Orton T, Pognan F (2000) Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity. Eur J Biochem 267:5421-5426.
28. Sittampalam GS (2004) Basics of Assay Equipment and Instrumentation for High Throughput Screening. In Sittampalam GS, Gal-Edd N, Arkin M, Auld D, Austin C, BejcekB, Glicksman M, Inglese J, Lemmon V, Li Z, McGee J, McManus O, Minor L, Napper A, Riss T, Trask OJ, Weidner J, (ed.), Assay Guidance Manual, Bethesda (MD).
29. Zhang JH, Chung TD, Oldenburg KR (1999) A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. J Biomol Screen 4:67-73. (Pubitemid 29278954)
30. Macarron R, Hertzberg RP (2009) Design and implementation of high-throughput screening assays. Methods Mol Biol 565:1-32.